Bayer AG NABAYN
▲ PositiveRegulationrelevance
Court ruling advances settlement, reducing legal uncertainty for Bayer.
Impact on stocks 1
Health Care
Bayer AG NABayer's $7.25 Billion Roundup Settlement Survives Court Challenge
Regulation
Bayer's $7.25 billion Roundup settlement survived another legal hurdle as the Eighth Circuit rejected an objectors' challenge, keeping the case in Missouri state court where a review is scheduled for September 14. The settlement covers roughly 65,000 current US claims, though the per-claim figure of about $111,500 is not a projected payout, as the structure also includes future cases and individual allocations. Shares traded at $14.10, about 84.8% above the $7.63 GF Value estimate, indicating investors expect a stronger outcome. The ruling advances the process but does not finalize it, as Bayer still needs final approval and a framework that withstands further objections.
Bayer AG NACourt ruling advances settlement, reducing legal uncertainty for Bayer.